TLR9 and prostate carcinoma: Although TLR9 expression is not associated with most markers of disease pathogenesis and progression (e.g., pT-class, Gleason score, and preoperative PSA level); it is associated with prostate cancer-specific progression-free survival in prostate cancer patients who have been treated by radical prostatectomy with curative intent (88).